Navigation Links
Professor Leroux From ETH Receives the Debiopharm Life Sciences Award 2010
Date:9/2/2010

rmaceutical Technology". Professor Leroux is an expert in galenic studies from the Swiss Federal Institute of Technology (ETH) in Zurich. He and his institute received CHF 100'000. Funded by Debiopharm, the ceremony took place at the EPFL (Ecole Polytechnique Federale de Lausanne) during the EPFL School of Life Sciences Symposium entitled "Engineering Life".

"We congratulate Professor Leroux for his outstanding research," said Rolland-Yves Mauvernay, President and founder of Debiopharm Group(TM). "A panel of experts from Debiopharm and the EPFL examined many high-level and promising applications from all over Europe; our decision to nominate Professor Leroux was unanimous. We were seduced by his innovative research, his general expertise and broad overall knowledge in drug delivery. The application file submitted by Professor Leroux was very comprehensive, with an impressive list of publications in high-impact factor pharmaceutical, materials and biomedical journals. He is a leading figure in an area that is likely to revolutionise medical therapeutics in the years to come."

The development of suitable drug formulations and delivery systems remains a major challenge in the full drug product development and industrialisation process. In his applied research, Professor Leroux is interested in the design of new carriers and materials for various pharmaceutical applications such as drug detoxification and the treatment of celiac disease (intolerance to gluten). Currently different approaches are being assessed as a supportive treatment of celiac disease. The polymeric binder technology which was developed in his laboratory will be further investigated. In parallel, he will examine another known strategy to study the stability of enzymes (exogenous propyl endopeptidases) in the gastro intestinal tract and try to improve it with various new polymers. He will also elaborate imaging tools to study in real time the enzymatic activity in vivo. Professor Leroux
'/>"/>

SOURCE The Debiopharm Group
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Professor-turned-producer learns the movie biz
2. UCF professor develops vaccine to protect against black plague bioterror attack
3. Stuart Parkin first distinguished professor at Eindhoven University of Technology
4. Yale professor T.P. Ma awarded the Connecticut Medal of Technology
5. UCF professor develops vaccine to protect against black plague bioterror attack
6. Kiadis Pharma Announces Continued Collaboration With Professor Velardi on its Lead Product ATIR(TM)
7. Gift Aids Professor's Research into Vein Treatment
8. Thin films research lands engineering professor Air Force Young Investigator Award
9. Nyenrode Honorary Doctorate for Professor Michael E. Porter
10. Professor K. C. Nicolaou Speaks at WuXi AppTec
11. Professors Raphael Haftka and C. T. Sun to receive AIAA-ASC James H. Starnes, Jr. Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... , December 23, 2014 ... Algeria , out today and available for free download ... actors driving change and growth in the sector today. ... scored notable successes has been in developing a homegrown pharmaceutical ... percent local production still remains some way off. A cursory ...
(Date:12/24/2014)... Dec. 23, 2014  Rock Creek Pharmaceuticals, Inc., (NASDAQ: ... filed a Clinical Trial Application (CTA) with the ... Agency (MHRA) seeking regulatory approval to initiate clinical trials ... Citrate. Contingent on the Company receiving CTA ... I trial to assess the safety, tolerability and dose ...
(Date:12/22/2014)... Brussels (PRWEB) December 22, 2014 The ... the global leader of technical training across the life ... Clinical Data Management (SCDM) to provide the organization's ... certification programs —providing access to the more than 350 ... SCDM members with 10% off when registering for a ...
(Date:12/22/2014)... - RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSX.V: RP), ... development of autologous cell therapies, announced today the publication ... in conjunction with co-authors from Kyoto University and the ... ongoing clinical research using dermal sheath cup (DSC) cells ... The paper entitled " Hair Follicle Dermal Stem Cells ...
Breaking Biology Technology:PharmaBoardroom Releases New Algeria Pharmaceuticals Report 2PharmaBoardroom Releases New Algeria Pharmaceuticals Report 3Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 2Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 3CfPIE Announces Partnership with the Society for Clinical Data Management 2CfPIE Announces Partnership with the Society for Clinical Data Management 3Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 2Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 3Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 4Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 5
...  Verenium Corporation (Nasdaq: VRNM ), a leading ... of high-performance enzymes, today announced that James Levine, Executive ... the upcoming Baird 2011 Clean Technology Conference.  The presentation ... Thursday, December 1, 2011 and will take place at ...
... Inc. (OTCBB: MDRM) (the "Company") is pleased to announce ... its closing agreement to acquire all of the common ... Mobility Aids, Inc. is a Nevada-based Company whose strategic ... Bio-Pharma sector as well as scalable manufacturing in niche ...
... Santa Barbara, Calif. Professor Kaustav Banerjee, a ... the Nanoelectronics Research Lab at the University of California, ... international research award by the Electrostatic Discharge Association (ESDA). ... competitive and meant to recognize cutting edge research ideas ...
Cached Biology Technology:Verenium to Present at Baird Clean Technology Conference 2Verenium to Present at Baird Clean Technology Conference 3Modern Mobility Aids, Inc. Secures Financing to Close Acquisition Agreement of LumiGene Technologies 2Modern Mobility Aids, Inc. Secures Financing to Close Acquisition Agreement of LumiGene Technologies 3UCSB professor receives award for graphene electronics research 2
(Date:11/21/2014)... DALLAS , November 18, 2014 ... Security Systems Market by Systems (Video, RFID, Access Control, ... (SEZ, Factories, Hotels, Banks, Government), Component Service Geography - ... Security Systems Market is projected to be around $25 ... Billion by 2020, growing at a CAGR of 8.69%. ...
(Date:11/21/2014)... , Nov. 20, 2014 C-Labs LLC, ... the Internet of Things (IoT), today announced the appointment ... chief operating officer. Previously a strategic advisor to the ... and operations. Mr. Traynor is based out of the ... He reports to Chris Muench , Chief Executive ...
(Date:11/18/2014)... 17, 2014   News Highlights: ... to develop The Partners Data Lake, an agile ... Data Lake will allow researcher and clinicians to ... and the lives of patients , The ... activities across the Partners system, breaking down physical ...
Breaking Biology News(10 mins):Industrial Security Systems Market Worth $38 Billion by 2020 2Industrial Security Systems Market Worth $38 Billion by 2020 3C-Labs Names Former Microsoft and Bsquare Executive as Chief Operating Officer 2Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 2Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 3Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 4Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 5
... the University of Leicester are investigating how the stuff of ... the human reproductive system. Hydrogen sulphide partially responsible for ... gas and has been used for chemical warfare. But ... beneficial effects it has in the body- and the potentially ...
... way to turn off a key signaling pathway involved in ... and other diseases. The findings may lead to new treatments ... In the study, which is currently available in the online ... that by activating a receptor in cells called the liver ...
... billionths of a millimeter in size. Exhibiting novel and often ... stream of equally innovative products. In medical therapies, for example, ... into cells. So far, the only way of testing these ... show the activation of a transported gene inside a ...
Cached Biology News:UCLA researchers discover new molecular pathway for targeting cancer, disease 2Chasing tiny vehicles 2Chasing tiny vehicles 3
... Contents include: Microarray hybridization chamber ... chamber top, clamp, thumbscrew) Microarray chamber user ... and are intended to be cleaned and ... with Agilents Catalog Oligo Microarray kits and ...
Formula variant: With the macro- and micronutrients as described by Lloyd and McCown (1981). Preparation Quantity Equivalency: Formulated to contain 2.3 grams of powder per liter of medium. Physical ...
... Staining Kit is a very sensitive immunohistochemical ... cells, containing both anti-von Willebrand Factor and ... a variety of species. This AP kit ... staining of frozen and paraffin-embedded sections in ...
... For separation ... proteins Efficient separation of nuclei ... reduction in sample complexity, greatly ... proteins Subfractionation of nucleic acid ...
Biology Products: